Werkgroep Cardiologische centra Nederland English

Dapa-HF (Includerend)

An International, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure with Reduced Ejection Fraction

Middel
dapagliflozin
Populatie
hartfalen
Fase
III
Jaar aanvang
2016